• Kilovoltage Stereotactic Radiosurgery for Age-related Macular Degeneration: Assessment of Optic Nerve Dose and Patient Effective Dose
• Stereotactic targeting and dose verification for age-related macular degeneration

• 4/7/2010 - Oraya Therapeutics Granted European CE Mark for the IRay Stereotactic Radiotherapy System
• 1/5/2010 - Oraya Therapeutics Initiates First Ever Sham-Controlled Study of Radiation Therapy for Wet AMD

For inquiries regarding Oraya Therapeutics or the IRay™ stereotactic radiosurgical device, please send an email to info@orayainc.com.

For inquiries regarding employment at Oraya Therapeutics, please send an email to HR@orayainc.com.

To reach the Oraya Therapeutics file exchange website, please click here.
To reach the Oraya Therapeutics web mail site, authorized users please click here.
To reach the Oraya Therapeutics VPN site, authorized users please click here.

Oraya Therapeutics, Inc.

8000 Jarvis Ave.
Newark, CA 94560
(510) 456-3700